Novel Antibodies to the C2-set Domain of CD33 for Acute Myeloid Leukemia Immunotherapy |
Fred Hutchinson Cancer Research Center |
Northwestern Mutual Foundation |
Accessing Combinatorial Effect of PARP Inhibitor with DNA Damaging Agent in Rhabdomyosarcoma at Single Cell Resolution |
Massachusetts General Hospital |
Flashes of Hope |
Cooperating Signaling Networks Regulate Cell Survival of Pediatric Ph-like ALL |
University of Pennsylvania |
Kate's Cause |
Beyond Febrile Neutropenia: Risks Associated with Antibiotic Choice in Children with Leukemia that Undergo Transplant |
Children’s Hospital of Philadelphia |
Love Your Melon |
Pedi-PRESTO: Pediatric Patient-Reported Symptom Tracking in Oncology |
Children’s Hospital of Philadelphia |
Tap Cancer Out |
Interrogation of Neuroblastoma Dependencies and RNAs on the Core-Regulatory Circuitry for Therapeutic Inhibition |
St. Jude Children’s Research Hospital |
Northwestern Mutual Foundation |
Exploring Synthetic Lethality of One-Carbon Metabolism Genes and mTORC1 Inhibition in MYCN Amplified Medulloblastoma |
University of California Berkeley |
The Swifty Foundation |
Be a Dog’s Best Friend, Help a Child |
Oregon State University |
Northwestern Mutual Foundation |
PDL-1 Expression on Tumor Cells Mediates C8 Cytotoxic T Cell (CTL) Resistance |
Ohio State University |
Northwestern Mutual Foundation |
Targeted Inhibition of CREB for the Treatment of Pediatric Acute Myeloid Leukemia |
Oakland University |
Northwestern Mutual Foundation |